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Abstract
Background: Our study set out to determine the prevalence of depressive symptoms and
variables that influence its presence in patients hospitalized for heart failure. Depression is
associated with a substantially increased risk of developing heart failure in individuals at
risk, and has been related to adverse outcomes in patients with established heart failure. It is
important to determine its prevalence in different populations and assess related causes.
Methods: We conducted a cross-sectional study of 103 patients with heart failure, admitted to
public hospital, via a questionnaire that evaluates clinical variables, socio-demographics and
we applied the Beck Depression Inventory to determine the prevalence of depressive symptoms
and predictors of their presence. We used the c2, Student test and considered significant when
< 0.05 and subjected to logistic regression analysis when between 0.05 and 0.1.
Results: The mean age of the patients in our study was 65.4 ± 13.6. Depressive symptoms
were present in 69 (67%) patients: 35 (34%) had mild depressive symptoms, 22 (21.3%) had
moderate symptoms and 12 (11.6%) patients presented severe symptoms. Marital status was
significant when analyzed, and the predictors of depressive symptoms were marital status, sex,
living arrangements and heart failure etiology.
Conclusions: Because depressive symptoms in patients hospitalized for heart failure are very
common, it is important to detect these disorders. The prevalence of these varies according to
socio-demographic and clinical data, and these factors should be taken into consideration
when planning future studies, as well as screening and intervention programs for co-morbid
depressive disorders in hospitalized patients with heart failure. (Cardiol J 2011; 18, 1: 18–25)
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Introduction
Heart failure (HF) is characterized by markedly
compromised cardiac function, a high rate of com-
plications, and decreased life expectancy [1]. Im-
paired cardiac function and neurohumoral activation
are the defining characteristics of HF that contrib-
ute to clinical deterioration, and the focus of inter-
ventions has generally been on improving circula-
tory function and on blocking the rennin–angio-
tensin and sympathetic nervous systems [2].
The presence of depressive symptoms (DS) is
widely considered a significant risk factor in patients
with coronary heart disease [3].  DS is associated
with a substantially increased risk of developing HF
in individuals at risk [4] and has been associated
with adverse outcomes in patients with established
HF [5]. Most studies on DS in patients with HF have
focused on hospitalized patients, with a prevalence
ranging from 13–77.5% [5–8]. The factors associ-
ated with DS in patients with HF have been con-
troversial. Freedland et al. [9] found that age, gen-
der, employment status, past history of depression
and functional severity of illness are associated with
DS in hospitalized patients with HF. In later stud-
ies on outpatients, Gottlieb et al. [10] found signif-
icant association equally among depression and age,
gender and functional status.
These studies have all been done in western
cultures. Research of literature, both manual and
electronic, reveals few studies on DS in Brazilian
patients with HF. At the same time, studies have
suggested that patients in developing countries (and
those of lower socio-economic status) often report
somatic symptoms and deny psychological symp-
toms more frequently than patients in western or
developed countries [11, 12].
With the potential importance of DS in the qual-
ity of life of patients with HF, a DS prevalence and
predictors study of Brazilian patients with HF is
therefore warranted. This study aims to estimate
the prevalence of DS and examine the socio-demo-
graphic and clinical factors associated with DS in
Brazilian hospitalized patients with HF.
Methods
This is a cross-sectional study of patients with
HF consecutively admitted to the cardiology ward
in three public hospitals. Patients were recruited
over a period of three months. All patients admit-
ted had a previous diagnosis of HF or were diag-
nosed when admitted through the Boston criteria.
The ejection fraction of left ventricle was assessed
by transthoracic echocardiography with Simpson’s
method and those included in this were < 50%.
Exclusion criteria included: concomitant diagnosis
of serious cancer, use of antidepressants in the 30 days
prior to admission, disorders that prevented under-
standing and communication with the researcher,
history of alcohol abuse or dependence in the last
six months, psychotic symptoms, history of psycho-
sis, bipolar disorder, dementia (or mental state
score < 23) or inability to sign the informed con-
sent form.
Procedures
Participants were first given a questionnaire
regarding socio-demographic data such as age, sex,
marital status, employment, educational level and
monthly income. The disease assessment was made
by evaluating the functional class of New York Heart
Association (NYHA) and obtained information about
the cardiovascular risk factors, etiology of HF and
treatment administered. The patient’s race was not
considered, due to the mixed characteristic of the
Brazilian population. We obtained informed consent
from all patients. The study was approved by the
ethics committee in research.
The severity of HF was measured by functional
class of NYHA [13]. This scale is used to quantify
the degree of functional limitation imposed by HF.
Four classes are assigned depending on the degree
of effort required to cause symptoms. Patients may
have symptoms of HF at rest (class IV) during dai-
ly activities (class III), when performing normal
activities (class II) or only during those activities
which limit normal individuals (class I) [14]. Demo-
graphic variables (age, sex, education level, mari-
tal status, housing conditions, presence or absence
of fixed monthly income, living arrangements) were
obtained by self-report at interview. No patients
were in functional class I, because only hospitalized
patients were included in the study. Co-morbidities
and medications in use were studied.
To identify DS, the Beck Depression Invento-
ry II was administered (BDI) [15, 16] to all patients
in the study within five days of hospitalization. This
scale, validated in Brazil and currently used in sim-
ilar international studies, allows the identification
of DS and theirintensity via a score obtained by
21 indicator items. The score ranges from 0 to 63,
according to Beck, distributed as follows: from 0 to
9 depression is considered absent, between 10 and
18 it is considered mild to moderate, between 19
and 29 it is considered moderate to severe, and
above 30 it is considered severe. We considered as
having DS those ≥ 10 points. The BDI [17] was used
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to measure DS. This scale includes 21 symptoms
and attitudes, covering emotions, behavioral chang-
es, and somatic symptoms. In addition to the original
scale, we computed the score excluding somatic
symptoms (fatigue, sleep and appetite disturbances)
that may result from HF rather than DS, and might
therefore lead to an overestimation of the associa-
tion between DS and heart failure stages. The ap-
plication of the questionnaire was performed by
physicians previously trained on the method [18].
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Statistical analysis
Participants were classified as patients with
DS, and without DS, based on the questionnaire
adopted. The results were calculated as frequencies
(%), mean and standard deviation. The c2 and Fish-
er’s exact test were used to determine whether
socio-demographic and clinical factors have any
relation to DS. The level of significance was < 0.05.
Variables with a value between 0.05 and 0.1 were
included in logistic regression analysis to determine
the predictive power of DS. The odds ratio (OR) and
confidence interval (CI) 95% were calculated on
predictor variables.
Results
Characteristics of the sample
Most patients were female (63.1%), married
(50.5%), literate (73.8%) and less than half of them
had a regular monthly income (43.7%). The vast
majority belonged to functional classes II and III
(75.2%). Hypertension was present in almost all
samples (92.2%). Non-ischemic etiology was de-
fined as the commonest cause of HF (57.3%). The
baseline characteristics of the sample are present-
ed in Table 1.
Prevalence of depressive symptoms
The study sample was analyzed using the BDI:
69 (67%) patients with DS were identified. When
evaluated, 35 (34%) had mild DS, 22 (21.3%) had
moderate symptoms and 12 (11.6%) patients pre-
sented with severe symptoms.
Correlates of depressive symptoms
Patients were divided into two groups with
bases in the presence or absence of DS according
to BDI. Univariate analyses were performed by c2
test or Fisher’s exact test as presented in Tables 2
and 3. The only significant variable was marital sta-
tus (p = 0.03). When analyzing the variables for
proper verification of the predictive variables for DS
with p < 0.10, we considered gender, living arrange-
Table 1. Baseline characteristics.
Socio-demographic factors
Age (mean\SD) 65.4 (13.6%)
Sex Male 38 (36.9%)
Female 65 (63.1%)
Educational level Illiterate 27 (26.2%)
Literate 76 (73.8%)
Marital status Married 51 (49.5%)
Not married 52 (50.5%)
Monthly income Have 45 (43.7%)
Don’t have 58 (56.3%)
Housing status Homeowners 65 (63.1%)
Not homeowners 38 (36.9%)
Living Alone 29 (28.1%)
arrangements Not alone 74 (71.9%)
CV risk factors
Hypertension 95 (92.2%)
Diabetes mellitus 35 (34%)
Dyslipidemia 47 (45.6%)
Sedentary 85 (82.5%)
Smoking 36 (35%)
Alcohol consumption 22 (21.4%)
Family history of CV disorders 95 (92.2%)
NYHA classification
II 35 (34%)
III 43 (41.2%)
IV 25 (24.3%)
Drug treatment
ACEI 69 (67%)
Inhibitors of angiotensin II receptor 31 (30.1%)
Adrenergic beta-blockade 81 (78.6%)
Thiazide diuretics 21 (20.4%)
Aldosterone inhibitors 50 (48.5%)
Calcium channel blockers 20 (19.4%)
Oral nitrates 33 (32%)
Aspirin 66 (64.1%)
Oral anticoagulation 10 (9.7%)
Digitalis 45 (43.7%)
Thienopyridine 5 (4.8%)
Arterial vasodilators 2 (1.9%)
Statins 43 (41.7%)
Loop diuretics 59 (57.3%)
Heart failure etiology
Ischemic 44 (42.7%)
Non-ischemic 59 (57.3%)
CV — cardiovascular; ACEI — angiotensin converting enzyme inhibitors
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Table 2. Comparison between patients with depressive symptoms (DS) and without depressive
symptoms related to clinical variables.
Variables All patients DS presence No DS P
CV risk factors
Hypertension 95 (92.2%) 67 (70.5%) 28 (29.5%) 0.35
Diabetes mellitus 34 (33.0%) 23 (67.6%) 11 (32.4%) 0.56
Dislipidemia 47 (45.6%) 30 (63.8%) 17 (36.2%) 0.42
Sedentary 81 (78.6%) 56 (69.1%) 25 (30.9%) 0.44
Smoking 23 (22.3%) 13 (56.5%) 10 (43.5%) 0.23
Alcohol consumption 20 (19.4%) 17 (85.0%) 3 (15.0%) 0.08
Other variables
Anemia 39 (37.9%) 29 (74.3%) 10 (25.7%) 0.26
COPD 12 (11.6%) 8 (66.7%) 4 (33.3%) 0.60
Hypothyroidism 6 (5.8%) 5 (83.3%) 1 (16.7%) 0.36
CRF 6 (5.8%) 6 (100%) 0 (0%) 0.09
Atrial fibrillation 21 (20.4%) 14 (66.7%) 7 (33.3%) 0.58
Drug treatment
ACEI 69 (67.0%) 45 (65.2%) 24 (34.3%) 0.46
ARB II 31 (30.0%) 24 (77.4%) 7 (22.6%) 0.18
Adrenergic beta-blockers 83 (80.5%) 54 (65.0%) 29 (35.0%) 0.45
Thiazide diuretics 21 (20.3%) 15 (71.4%) 6 (28.6%) 0.45
Aldosterone inhibitors 50 (48.5%) 38 (76.0%) 12 (24.0%) 0.17
Calcium channel blockers 20 (19.4%) 15 (75.0%) 5 (25.0%) 0.33
Oral nitrates 33 (32.0%) 22 (66.7%) 11 (33.3%) 0.56
Aspirin 57 (55.3%) 45 (79.0%) 22 (21.0%) 0.55
Oral anticoagulation 10 (9.7%) 5 (50.0%) 5 (50.0%) 0.22
Digitalis 43 (41.7%) 30 (69.7%) 13 (30.3%) 0.45
Thienopyridine 5 (4.8%) 3 (60.0%) 2 (40.0%) 0.53
Hydralazine 2 (1.9%) 1 (50.0%) 1 (50.0%) 0.55
Loop diuretics 59 (57.2%) 46 (80.0%) 13 (22.0%) 0.12
NYHA classification (FC)
II 36 (34.9%) 25 (69.4%) 11 (30.6%)
III 42 (40.8%) 27 (64.3%) 14 (35.7%) 0.47
IV 25 (24.3%) 17 (68.0%) 8 (32.0%)
Heart failure etiology
Ischemic 43 (41.7%) 33 (76.7%) 10 (23.3%)
0.05
Non-ischemic 60 (58.3%) 36 (60.0%) 24 (40.0%)
CV — cardiovascular; COPD — chronic obstructive pulmonary disease; CRF — chronic renal failure; ACEI — angiotensin-converting enzyme inhibitors;
ARB — angiotensin receptor blockers; FC — functional class
ments, alcohol consumption, chronic renal failure
and HF etiology. The variables that were not con-
firmed as a predictor of DS were alcohol consump-
tion and chronic renal failure, presented in Table 4.
The OR and CI 95% are presented in Table 5.
Discussion
Many disturbances are common between HF
and DS and they act during the continuum that leads
up to overt HF. Particularly, neurohormonal acti-
vation is initially triggered as an adaptive response,
but it eventually becomes maladaptive and perpet-
uates the process through a positive feedback
mechanism. Moreover, precursors and risk factors
for HF, namely coronary heart disease (as cause,
consequence, and prognostic factor), hypertension
[19], diabetes mellitus [20], obesity [21, 22], smok-
ing [23], and excessive alcohol consumption [24],
are, themselves, related to a higher prevalence of
DS. If the higher prevalence of DS in HF patients
is mainly a consequence of the association with
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those risk factors, we would expect this effect to
be already present in asymptomatic precursors of
HF. If, however, DS acts mainly through changing
perceptions and symptoms (that is, if depressed
patients are simply more sensitive to symptoms and
express more severe fatigue, dyspnea and function-
al impairment with the same objective cardiac phys-
iological abnormalities) then it should be associat-
ed only or mainly with symptomatic HF.
Depression prevalence and characteristics
in patients with heart failure
In this study, 11.6% of the patients were con-
sidered as having severe DS and 21.3% as moder-
ate. The prevalence of DS among patients with HF
has varied widely, reflecting differences in popula-
tions and methods of diagnosing DS [8, 24–27]. Four
studies that used the self-administered Center for
Epidemiologic Studies Depression Scale reported
depression prevalence from 24.4% to 58% [8, 28–30].
The one that used the self-administered Zung tool
Table 4. Logistic regression analysis to
determine predictors of depressive symptoms
in patients hospitalized for heart failure
Variables b t p
Sex 0.55 4.4 < 0.0001
Living arrangements 0.45 3.19 00.002
Alcohol consumption –0.46 –1.08 0.28
Chronic renal failure –0.31 0.13 0.71
Heart failure etiology 0.74 5.98 < 0.0001
Table 5. Variables predictive for depressive symptoms in patients with heart failure found in logistic
regression.
Variable Odds ratio (95% CI)
Sex: male vs female 1.10 (0.47–2.60)
Marital status: married vs not married 0.45 (0.19–1.06)
Living arrangements: live with another vs live alone 0.45 (0.16–1.25)
Heart failure etiology: ischemic vs non-ischemic 2.20 (0.91–5.28)
Table 3. Comparison between patients with depressive symptoms (DS) and without depressive
symptoms related to socio-demographic variables.
Variables All patients DS presence No DS P
Age 65.43 (13.66%) 66.56 (13.18%) 63.14 (14.50%) 0.26
Socio-demographic variables
Sex
Male 38 (36.9%) 26 (68.4%) 12 (31.6%)
0.06
Female 65 (63.1%) 43 (66.1%) 22 (33.9%)
Marital status
Married 52 (50.5%) 31 (59.6%) 21 (40.4%)
0.03
Not married 51 (49.5%) 39 (76.4%) 12 (23.6%)
Monthly income
Have 45 (43.6%) 29 (64.4%) 16 (35.6%)
0.32
Don’t have 58 (56.4%) 41 (70.7%) 17 (29.3%)
Educational level
Literate 75 (72.8%) 52 (69.3%) 23 (30.7%)
0.39
Illiterate 28 (27.2%) 8 (64.3%) 10 (35.7%)
Living arrangements
Live with others 74 (71.8%) 47 (63.5%) 27 (36.5%)
0.09
Live alone 29 (28.2%) 23 (79.3%) 6 (20.7%)
Housing status
Homeowners 63 (61.1%) 41 (65.0%) 22 (35.0%)
0.57
Not homeowners 37 (38.9%) 26 (70.3%) 14 (29.7%)
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reported a 13% prevalence [31] and the one that
used the self-reported Geriatric Depression Scale
Short-Form reported a 77.5% prevalence [32]. Sul-
livan et al. [25] used the Primary Care Evaluation
of Mental Disorder psychiatric diagnostic interview
sections on depression, anxiety and alcohol disor-
ders, finding a rate of 29% for 142 outpatients with
advanced HF having major DS (16%), dysthymia
(11%), and/or minor DS (8%). In our sample, the
overall prevalence of DS was 69 (67%) patients.
Furthermore, although patients with non-is-
chemic etiology of HF were reported to have a lower
prevalence of DS in a study of 396 patients [33], the
prevalence of DS did not differ significantly by HF
etiology in our study. The prevalence of DS like-
wise did not differ significantly by sex, although the
recent National Comorbidity Survey reported a life-
time odds ratio for DS for women compared to men
of 1.7 [34]. In another study, female gender was
associated with DS when criteria for severe DS
were used, but DS prevalence did not vary by sex
when DS was defined as a BDI [9]. Three other
studies have also found no significant link between
sex and DS [8, 32, 33]. The pathophysiologic link
between DS and HF therefore may not be related
to sex. In our study, sex was considered a predic-
tor variable for the DS presence, although it is still
considered controversial.
Predictors of depressive symptoms
Marital status was the risk factor for DS in our
study. Although advancing age was associated with
increasing DS, it was not related to a higher preva-
lence. This has been noticed in some previous stud-
ies [8, 9] but not in others [32, 33]. Koenig [8] found
that a composite measure of medical illness sever-
ity independently predicted DS in patients with HF,
whereas others reported that patients with greater
HF symptoms were more likely to be depressed [9,
32–35]. A link between DS and NYHA classification
(but not ejection fraction) may explain why some
patients with HF with lower ejection fractions re-
main asymptomatic, while others with higher ejec-
tion fractions are physically limited because of sig-
nificant fatigue or dyspnea. Such findings suggest
each of them has independent predictability for sur-
vival. Depressive symptoms are a risk factor for
ischemic heart disease development as well as for
poor prognosis, once it is manifested [36]. In our
study, we submitted the following variables to lo-
gistic regression analysis: sex, living arrangements,
alcohol consumption, chronic renal failure and HF
etiology. Variables that were confirmed as predic-
tors of DS in our sample were sex, living arrange-
ments and HF etiology.
Havranek et al. [23] identified four independent
predictors associated with the development of de-
pressive symptoms among 245 outpatients with HF,
as measured by the Medical Outcomes Study-De-
pression tool: (1) living alone, (2) alcohol abuse,
(3) perceived financial burden from medical care,
and (4) worse baseline HF-specific health status as
measured by the Kansas City Cardiomyopathy
Questionnaire. Patients who developed depressive
symptoms at one-year follow-up were more likely
to live alone (40% vs 23%, p = 0.015), have a histo-
ry of alcohol abuse (23% vs 11%, p = 0.013), and
perceive medical care as an economic burden (60%
vs 34%, p = 0.003). The Kansas City Cardiomyop-
athy Questionnaire summary scores of 60 vs 71
were worse in patients who developed significant
depressive symptoms at one year (p < 0.001). For
patients with one, two, and three risk factors, the in-
cidence of significant depressive symptoms at one
year was 16%, 36%, and 69%, respectively. There
were no significant differences between the patients
who developed depressive symptoms and the patients
who did not regarding age, race or marital status [23].
These include high activation of the hypotha-
lamic-pituitary-adrenal axis and intra-abdominal fat
content [37, 38], elevated plasma norepinephrine,
increased heart rate, reduced heart rate variability
[39, 40], increased platelet aggregation [41], and
elevated plasma levels of proinflammatory cytok-
ines such as tumor necrosis factor, interleukin-1,
the interleukin-6 family [42, 43] and C-reactive pro-
tein [44]. Mental stress-induced myocardial is-
chemia, a risk factor for the poor prognosis of car-
diac patients, is found to be associated with DS  [45].
Moreover, DS adversely affects patient adherence
to recommended interventions.
In contrast to its strong association with func-
tional class, severe DS is associated with medical
co-morbidity. However, the variables in our sam-
ple were not related to severe DS in the univariate
analysis and were not retained as independent cor-
relates. There was no difference in terms of educa-
tion, income, housing conditions or beta-blockade.
Beta-blockers improve prognosis in HF, but doctors
may be reluctant to prescribe them for depressed
patients. If this increases the risk of morbidity and
mortality it should be investigated. Independent
predictors included sex, living arrangements and
etiology of HF. Most of the correlations of major
depression also correlate with minor depression,
but not so strongly [43, 44].
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Limitations of the study
Unlike the previous studies of depressive dis-
orders in hospitalized patients with HF, both of
which were restricted to elderly patients, this one
also includes young patients. Because of its more
inclusive sample, the present findings provide bet-
ter estimates of the prevalence of DS in the popu-
lation of patients hospitalized with HF when com-
pared to earlier studies. The small sample may im-
ply limitations on the representativeness of the
results. Furthermore, this report identifies a num-
ber of patient characteristics that help to explain
why the observed prevalence of severe DS has var-
ied so widely across the studies.
Despite the cross-sectional design, the classi-
fication of subjects according to evolving stages of
HF allowed us to come closer to a longitudinal per-
spective and to demonstrate higher scores on a de-
pression scale in women at early, asymptomatic
stages of HF. These results show that the associa-
tion between DS and HF is not merely explained
by the emotional effect of medical illness. If future
studies confirm that depression contributes to
a more likely or faster progression of symptomatic
HF, we can make a clearer prediction of future HF.
Conclusions
Depressive symptoms are very common in
hospitalized patients with HF. Its prevalence var-
ies according to how DS is defined and according to
the patient’s demographic, medical and social char-
acteristics. Predictive factors such as gender, mar-
ital status, lifestyle and etiology of HF were impor-
tant to the presence of DS in the sample. These
factors should be taken into consideration when
planning future studies as well as screening and
intervention programs for co-morbid depressive
disorders in hospitalized patients with HF.
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